Optimization of a New Adaptive Intervention to Increase COVID-19 Testing
2 other identifiers
interventional
668
1 country
1
Brief Summary
This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. This study uses an integrated research collaborative framework that facilitates dialogue among researchers, community members, and service providers as a tool for optimizing the adaptive intervention and will take place at the North Jersey Community Research Initiative (NJCRI)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2021
CompletedFirst Submitted
Initial submission to the registry
February 15, 2021
CompletedFirst Posted
Study publicly available on registry
February 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 25, 2022
CompletedResults Posted
Study results publicly available
February 15, 2024
CompletedFebruary 15, 2024
February 1, 2024
1.7 years
February 15, 2021
October 13, 2023
February 14, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Stage 1: Completion of COVID-19 Test After First Randomization
For the first stage intervention, the primary outcome is coming to the agency and completing the COVID-19 antigen test one week after completing the baseline.
Stage 1: Within one week of completing baseline.
Stage 2: Reported COVID Test in Last 30 Days at 6 Months Post Baseline
For the second stage intervention, the primary outcome is self-reported completion of COVID-19 test in the past 30 days at the follow up completed 6 months after baseline. Study participants were asked whether they had completed a COVID-19 test in the past 30 days.
Stage 2: 6 months post baseline (4th follow up visit)
Study Arms (6)
Navigation only
OTHERParticipants are randomized to receive navigation services only.
Navigation + Brief Counseling
OTHERAfter initial randomization into NS, some participants are randomized to receive Brief Counseling (BC)
Navigation + Critical Dialogue
OTHERAfter initial randomization into NS, some participants are randomized to receive Critical Dialogue (CD)
Brochure only
OTHERParticipants are randomized to receive Brochure only.
Brochure + Brief Counseling
OTHERAfter initial randomization to receive a brochure, some participants are randomized to receive Brief Counseling (BC)
Brochure + Critical Dialogue
OTHERAfter initial randomization to receive a brochure, some participants are randomized to receive Critical Dialogue (CD)
Interventions
Navigation services include assessment and support with service referrals. Each participant will meet with a peer navigator in person or on Zoom Conferencing for 30 minutes to go over results from their social and health needs assessment that is retrieved from the baseline assessment. The navigator shares information about COVID-19, answers questions about testing, and makes referrals to other needed services
Critical Dialogue includes three one-hour-long, open-group-sessions facilitated in person or online by a trained licensed facilitator. Group critical dialogue is prompted by thematic images developed by the NCCB to foster a deeper understanding of how systematic stigma, feelings of rage as victims of discrimination, and/or apathy may impact participants' beliefs and behaviors related to COVID-19 and empower participants to make critical choices to protect their health and the health of their communities.
Brief Counseling is a 15-minute post-COVID-19 test session delivered by a trained licensed clinician in person or via Zoom Conferencing. In the session, the clinician shares the test results and offers recommendations and information about COVID-19 treatment and prevention.
Referral will consist of a five-minute phone call where an outreach worker offers participants information about COVID-19 testing and encourages them to get tested within one week. A digital brochure containing NJ recommendations is e-mailed or texted to participants.
Eligibility Criteria
You may qualify if:
- over 18 years of age
- having high risk to contract COVID or develop related complications
- able to speak English
- able and willing to provide informed consent.
You may not qualify if:
- under 18 years of age
- not at high risk to contract COVID or develop related complications
- unable to speak English
- unable and unwilling to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
North Jersey Community Research Initiative
Newark, New Jersey, 07102, United States
Related Publications (3)
Lee CA, Gamino D, Lore M, Donelson C, Windsor LC. Use of research electronic data capture (REDCap) in a sequential multiple assignment randomized trial (SMART): a practical example of automating double randomization. BMC Med Res Methodol. 2023 Jul 6;23(1):162. doi: 10.1186/s12874-023-01986-6.
PMID: 37415099DERIVEDLee CA, Gamino D, Lore M, Donelson C, Windsor LC. Use of research electronic data capture (REDCap) in a sequential multiple assignment randomized trial (SMART): A practical example of automating double randomization. Res Sq [Preprint]. 2023 Feb 24:rs.3.rs-2573133. doi: 10.21203/rs.3.rs-2573133/v1.
PMID: 36865151DERIVEDWindsor L, Benoit E, M Pinto R, Sarol J. Optimization of a new adaptive intervention using the SMART Design to increase COVID-19 testing among people at high risk in an urban community. Trials. 2022 Apr 14;23(1):310. doi: 10.1186/s13063-022-06216-w.
PMID: 35421999DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Note that 46% of the sample never completed follow-up 4.
Results Point of Contact
- Title
- Dr. Liliane Windsor
- Organization
- University of Illinois Urbana Champaign
Study Officials
- PRINCIPAL INVESTIGATOR
Liliane Windsor, PhD
University of Illinois Urbana Champaign
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 15, 2021
First Posted
February 17, 2021
Study Start
February 12, 2021
Primary Completion
October 25, 2022
Study Completion
October 25, 2022
Last Updated
February 15, 2024
Results First Posted
February 15, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ICF, ANALYTIC CODE
- Time Frame
- Upon request after the study is complete
- Access Criteria
- Must sign a data sharing agreement
De-identified data can be shared upon request for research purposes and under a data sharing agreement.